By Robert Cuyler, Ph.D.
When it comes to clinical treatment technologies, there are what seems to be a never-ending supply of options. To get a better understanding of tech innovations in practice OPEN MINDS recently spoke with Robert Cuyler, Ph.D., chief clinical officer for Palo Alto Health Science (PAHS), about how his organization’s new technology facilitates treatment of panic disorder. The treatment, Freespira, is a a novel, FDA-cleared intervention for the treatment of panic disorder and the symptoms of attacks in adults age 18 and older . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:
When it comes to clinical treatment technologies, there are what seems to be a never-ending supply of options. To get a better understanding of tech innovations in practice OPEN MINDS recently spoke with Robert Cuyler, Ph.D., chief clinical officer for Palo Alto Health Science (PAHS), about how his organization’s new technology facilitates treatment of panic disorder. The treatment, Freespira, is a a novel, FDA-cleared intervention for the treatment of panic disorder and the symptoms of attacks in adults age 18 and older . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!